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Background:  Quantitative myocardial perfusion imaging (MPI) has gained increasing interest over the last years and is expected to become a 
routinely used technique in clinical practice. One of the fundamental issues when performing quantitative MPI is to define limits of myocardial blood 
flow (MBF) in a clinically appropriate population. Furthermore, studies investigating the effect of sex and coronary artery disease (CAD) risk factors 
on MBF in a clinically appropriate population are scarce. The present study is aimed at defining the lower limit of normal MBF in a patient cohort in 
whom significant CAD has been excluded.
Methods:  A total of 128 patients (mean age 55 ± 10, 51 men) with a low to intermediate pre-test likelihood for CAD were referred for non-invasive 
evaluation of CAD on a hybrid PET-computed tomography (CT) scanner. MBF was quantified with [15O]H2O at rest and during adenosine induced 
hyperaemia. Obstructive CAD was excluded in these patients by means of invasive or CT based coronary angiography or the absence of coronary 
artery calcium (calcium score = 0).
Results:  Global baseline MBF averaged 0.96 ± 0.42 (range 0.48 -2.91) and 1.15 ± 0.31 (range 0.59 - 2.75) ml/min/g, in men and women, 
respectively (p < 0.01). However, no gender-dependent difference in baseline MBF was seen when corrected for rate-pressure product (1.49 ± 0.79; 
1.64 ± 0.46 ml/min/g, in men and women, respectively, p = 0.19). Global hyperaemic MBF averaged 2.87 ± 0.81 (range 1.52 - 4.95) and 3.90 ± 
1.37 (range 1.58 - 8.15) ml/min/g, in men and women, respectively (p < 0.001). Multivariate analysis identified gender, age, body mass index (BMI) 
and hypercholesterolemia to independently negatively impact hyperaemic MBF.
Conclusions:  Hyperaemic MBF in patients without apparent CAD shows distinct gender differences. The absolute lower limit of hyperaemic MBF, 
however, appears to be comparable for men and women. Therefore, using [15O]H2O PET, hyperaemic MBF values below 1.5 ml/min/g, should be 
considered pathological. Next to gender, age, BMI, and hypercholesterolemia independently impact hyperaemic MBF. Further studies including 
patients with varying degrees of CAD are warranted to define optimal cut-off values to detect CAD.
